Tag Archive: pharmaceutical industry.


 photo FamilySurvivalProtocolColliseumBannergrayscale900x338_zpsb17c85d0.jpg          Health and Wellness Report Banner photo FSPLogoBannerHealthandWellness831x338Blogger_zps68b43460.jpg

…………………………………………………………………………………..

NaturalNews's profile photo
NaturalNews

CDC exposed as private corporation colluding with Big Pharma to defraud American taxpayers: see the evidence

 

CDC corruption

(NaturalNews) The illusory notion that the federal regulatory agency known as the Centers for Disease Control and Prevention (CDC) is somehow a public entity working on behalf of the people to protect us all from disease is simply laughable.

The CDC, by definition, is a private corporation working on behalf of its stakeholders, which include key players in the pharmaceutical and vaccine industries that profit from the spread of disease, not from real prevention and cures.

The first and most obvious clue that the CDC isn’t what it appears on the surface is the fact that this supposed government agency is listed in the official Dun & Bradstreet (D&B) directory as a for-profit corporation.

D&B is a Fortune 500 company based in New Jersey that maintains databases on more than 235 million companies worldwide – it’s a who’s who of the global business climate, and is recognized as one of the first companies to be publicly traded on the New York Stock Exchange (NYSE).

Here’s a screenshot of the CDC’s listing on D&B, courtesy of the AntiCorruption Society:

image

Big Pharma and the CDC: one in the same

Anyone who tries to argue with you that the CDC is looking out for public safety as its first priority just needs to take a glance at D&B to see that the CDC is actually looking out for its own bottom line, and that of its corporate allies. Which brings us into our second piece of evidence that the CDC is a corrupt, drug-pandering sham – many of the CDC’s top health “experts” have ties to the pharmaceutical industry.

An investigation by the British Medical Journal (BMJ) and the Bureau of Investigative Journalism (BIJ) found that three key “scientists” who helped develop official swine flu policy for the World Health Organization (WHO), recommending that practically everyone be vaccinated, received cash payments from both Roche and GlaxoSmithKline (GSK), two pharmaceutical giants that manufacture swine flu vaccines.

These two companies, as reported by The Guardian in 2010, paid off policymakers in multiple countries, including in the U.S. (at the CDC), to write the WHO’s guidelines for swine flu that pushed dangerous swine flu vaccines on millions of people globally. With the help of the CDC and other corrupt agencies, these pharmaceutical corporations pocketed billions of dollars.

“The tentacles of drug company influence are in all levels in the decision-making process,” stated Paul Flynn, a British Member of Parliament who spoke out against this racket as it was occurring.

CDC pushes fake science promoting deadly drugs, vaccines

The CDC has also been complicit in forging fake science to push other dangerous vaccines like the MMR jab for measles, mumps and rubella. Robert F. Kennedy Jr. blew the lid on this scandal that same year, outing now-shamed scientist Poul Thorsen for stealing $2 million in research money while covering up the link between MMR and autism, which the CDC ate right up in its quest to protect the reputation of MMR.

Top CDC scientist Dr. William Thompson has also since come forward as a whistleblower to expose the CDC for manipulating research findings that showed MMR causes autism at a disproportionately higher rate in young black boys compared to other children – though MMR causes autism in all types of children, this same research found.

“As more and more ‘vaccination’ propaganda appears in the mainstream media, it is crucial that the American people become aware of the outrageous scam the CDC and the medical industrial complex are running,” warns the AntiCorruption Society.

“All that is needed is for folks to educate themselves and join the many good people (professionals and non-professionals) working to get the truth out.”

Sources for this article include:

AntiCorruptionSociety.com

TheGuardian.com

HuffingtonPost.com

NaturalNews.com

 

…………………………………………………………………………………….

 

About NaturalNews

The NaturalNews Network is a non-profit collection of public education websites covering topics that empower individuals to make positive changes in their health, environmental sensitivity, consumer choices and informed skepticism. The NaturalNews Network is owned and operated by Truth Publishing International, Ltd., a Taiwan corporation. It is not recognized as a 501(c)3 non-profit in the United States, but it operates without a profit incentive, and its key writer, Mike Adams, receives absolutely no payment for his time, articles or books other than reimbursement for items purchased in order to conduct product reviews.

The vast majority of our content is freely given away at no charge. We offer thousands of articles and dozens of downloadable reports and guides (like the Honest Food Guide) that are designed to educate and empower individuals, families and communities so that they may experience improved health, awareness and life fulfillment.

Learn More About Natural News Here

 photo FamilySurvivalProtocolColliseumBannergrayscale900x338_zpsb17c85d0.jpg          Global Community Report Banner photo FSPLogoGlobalCommunityFulloldworldmapbckgrnd_zps43d3059c.jpg

Health and Wellness Report Banner photo FSPLogoBannerHealthandWellness831x338Blogger_zps68b43460.jpg

…………………………………………………………………………………………..

 

TPP Deal Finally Revealed

Details of the long-secret Trans-Pacific Partnership are public at last: it will undermine the safety of our food supply, make medicine more expensive, and give power to the biotech monopoly. Action Alert!

A few weeks ago, the full text of the Trans-Pacific Partnership (TPP) trade deal was finally released after many years of closed-door negotiations between officials from the US and eleven other countries, all of whom border the Pacific Ocean. Its provisions were apparently kept secret from all but the biotech and pharmaceutical industries.

Leaked documents during the trade negotiations provided reason to be concerned about the final agreement. And now, a review of the deal’s twenty-nine chapters and five thousand pages proves these early concerns were completely justified. The final package now awaits a vote in Congress, which is likely to take place in Spring 2016.

Here are some of the most pressing concerns for natural health advocates:

It Undermines the Safety of the Food Supply

The TPP contains a number of provisions that threaten current food safety laws.

Generally speaking, passage of the TPP would mean that any US food safety law concerning things like pesticides, food additives, or labeling that is more stringent than “international standards” may be considered an “illegal barrier” to trade, and subject to enforcement. We have learned to beware of such “international standards.” They are largely determined by global special interests.

The TPP expands corporate power in other ways. The deal includes an investor-state dispute settlement (ISDS) system in which multinational corporations can challenge a host company’s regulations in an international court. ISDS has been a fixture in other trade treaties, including NAFTA (the North Atlantic Free Trade Agreement), and has been used to challenge countries’ economic policies, anti-smoking efforts, and environmental preservation laws. It is another giveaway to Big Food and other powerful multinational interests—a recurring theme throughout the TPP document.

The trade agreement also undercuts US efforts to inspect food imports. The agreement limits food import inspections at the border “to what is reasonable and necessary,” and if an issue arises, a country must also provide an “opportunity for a review of the decision.” This provision, referred to as the Rapid Response Mechanism, may give exporting countries the right to challenge basic food safety provisions in the US.

It Gives New Patent Protections to Big Pharma

The TPP contains an entire chapter on intellectual property rights, with many provisions relating to pharmaceutical patents. No doubt heavily influenced by the pharmaceutical industry, the trade deal will force signatory countries to accept many of the same patent laws that have kept drug prices so astronomically high in the US.

The deal would extend and broaden certain patent and data protections for the pharmaceutical industry, which Big Pharma can then use to keep prices high and delay competition from generics. It is a wonderful gift to the pharmaceutical industry—but a grave loss to patients in developing countries looking for access to affordable drugs.

The TPP also allows a practice known as “evergreening,” which lets drug companies extend a patent on an old drug when it can be used to treat a new condition—another boon for Big Pharma’s monopoly power.

Even when Big Pharma loses in the TPP, it wins. One of the more controversial topics in TPP negotiations concerned patent and data protections for biologic drugs—medicines derived not from inert chemical compounds but from living organisms. Big Pharma wanted twelve years of exclusivity— they already have this in the US—and US trade officials pushed hard in the negotiations to make this the standard. Instead, the deal grants them at least five years of exclusivity and as much as eight.

It’s Also a Gift to Biotech Seed Companies

Finally, the TPP deal expands biotech’s monopoly over the seed industry. The deal requires all twelve countries to join a number of global intellectual property treaties. One of these treaties is the 1991 International Convention for the Protection of New Varieties of Plants (UPOV91), which emphasizes the rights of seed companies over farmers. Among other things, UPOV91:

  • Requires intellectual property (IP) protection for all plant species;
  • Provides IP protection for 20 to 25 years; and
  • Stops farmers from exchanging seeds—a common and important practice in many developing nations and indeed throughout human history.

In countries that have not already turned agriculture over to the biotech industry, this could mean a substantial rewrite of regulations meant to protect farmers.

Other treaties that signatory countries are compelled to join make it easier to apply for patents—making it very likely that more plants and seeds will be patented.

If these gifts to industry were not enough, President Obama moved earlier this summer to have the deal “fast-tracked”—that is, Congress will be given a fixed period to review the agreement, after which time legislators must make a yes/no vote without the possibility of amending the deal. Essentially, it’s “take it or leave it.”

We say: leave it. And if the US does reject it, do not worry about losing the reduction of tariffs that is already included. There will just be a second (and, we hope, a better) version to replace it.

Action Alert! Write to your members of Congress and urge them to oppose the TPP deal, which undermines consumers and farmers and extends monopoly rights to major industries. Please send your message immediately.

Take-Action

 

Global Community Report Banner photo FSPLogoGlobalCommunityFulloldworldmapbckgrnd_zps43d3059c.jpg

Health and Wellness Report Banner photo FSPLogoBannerHealthandWellness831x338Blogger_zps68b43460.jpg

……………………………………………………………………………….

 

Paxil

Paxil , Wkimedia.org

……….

 

By Kristen Anderson

The FDA requires each new drug to undergo rigorous testing and stand up to scientific scrutiny, a process that is designed to protect consumers by thoroughly examining the effects of new medications before they are available to the public. But few people stop to realize that these studies which are mandated by the FDA, are actually funded by the drug companies themselves, clearly a conflict of interest.

Big Pharma has so much influence in the field of scientific research, that the professionals who depend on peer-reviewed studies, i.e. doctors, psychiatrists, nurses, etc., prefer to read meta-analyses as a way to ensure objectivity. These meta-analyses combine evidence from multiple studies to weed out studies that produced irregular or uncommon results. In this way, the meta-analysis is regarded as the purest form of research and is heavily relied on by medical professionals. But, again, if Big Pharma has essentially infiltrated the research industry to the point that the majority of studies are being skewed, even a meta-analysis is unreliable.

Take for example Study 329. GlaxoSmithKline funded Study 329 between 1994 and 1998 and the results showed that Paxil was safe for teenagers. This study was published in 2001 in the Journal of the American Academy of Child and Adolescent Psychiatry (JAACAP), a well-respected and peer-reviewed journal. It was later found, however, that the authors had downplayed the negative findings and that GlaxoSmithKline had actually hired a PR firm to ghost write the article! Paxil actually clearly increases suicidal thoughts and impulses among teenagers and this effect was downplayed in the article and not even addressed in the conclusion (the most-read section of a scientific study).

 

Read More Here

Health and Wellness Report Banner photo FSPLogoBannerHealthandWellness831x338Blogger_zps68b43460.jpg

 **************************************************
drug

 Outrageous Big Pharma greed on parade as $1 pill for treating fatal infection suddenly skyrockets to $750 PER PILL!

(NaturalNews) The total greed of Big Pharma is on parade this week as a company called Turing Pharmaceuticals took ownership of a lifesaving medication that treats parasitic infections like malaria. The pill — mostly purchased by AIDS and cancer patients — used to cost $1 each. But now, thanks to Turing Pharmaceuticals and its profiteering CEO Martin Shkreli, each pill will cost you $750.

Remarkably, The New York Times even covered the story, reporting, “Specialists in infectious disease are protesting a gigantic overnight increase in the price of a 62-year-old drug that is the standard of care for treating a life-threatening parasitic infection.”

“The drug, called Daraprim, was acquired in August by Turing Pharmaceuticals, a start-up run by a former hedge fund manager. Turing immediately raised the price to $750 a tablet from $13.50, bringing the annual cost of treatment for some patients to hundreds of thousands of dollars.”

This drug was priced at just $1 a few years ago. It went up to $13.50 over the last decade or so, and now has spiked to $750 per pill. This means a single treatment course could cost more than buying a home.

This is all explained by the “Taiwanese animators” in this highly educational animated short video:

 

Big Pharma greed on parade and out of control

Why is Turing Pharmaceuticals charging $750 a pill? Because they CAN. Like every other drug company in the world, they’re going to gouge the consumer and extract the maximum dollars possible. Big Pharma is really about the profits, you see, and not at all interested in “helping humanity” as their ridiculous TV ads claim.

Is it any wonder that 1 out of every 5 dollars spent in the U.S. economy is spent on “sick care” costs? Check out the following chart that shows how different countries spend money in different ways. Care to guess which country spends the most on health care? The United States by a long shot!

 

Read More Here

Lives ‘left in ruin’ by rising tide of depression drugs

More people are being put on the pills but some experts are now warning they do more harm than good. Julia Llewellyn Smith reports

Jo Thompson

Jo Thompson ended up in hospital on anti-anxiety pills, and wanted to die when she stopped them  Photo: Geoff Pugh/Telegraph

Twenty years ago, Henry was living a fulfilled life. A happily married father from the Home Counties, his sales career was going well, he had a wide social circle and played football and golf regularly. “I was a conservative, head-down, career-minded person who enjoyed my life,” he says.

But in 1995, a bout of flu left Henry, then 31, exhausted and lethargic. He visited his GP, who told him he was depressed, and prescribed the world’s most popular antidepressant, Prozac. “Everything appeared completely benign — he said depression was a common complaint, the drugs would fix it and then I’d stop taking them.”

More than a decade later, Henry was far from cured and still taking antidepressants. “None of the drugs I was prescribed made me feel better, and most made me considerably worse. But every time I stopped them, the symptoms of what I thought was depression — but now know were of withdrawal — returned even more strongly, so I went back to the pills.”

By 2009, he was so unwell that he had to give up work. Finally, suspecting the drugs were the cause of his problems, he quit them, only to enter a new hell.

“It was torture. I thought I was going to die, and I didn’t care. For two years, I was in severe physical pain and so weak I lay all day on the sofa. My cognition was severely affected, I was dizzy, with blurred vision, I couldn’t read a bedtime story to my son and couldn’t remember things that had happened just a few seconds previously.”

Henry — who does not want to reveal his last name because of pending legal action against the drugs manufacturers — is just one of an estimated four million people in Britain taking antidepressants, a number that is rising sharply.

Last year, 53 million prescriptions were issued for antidepressants in England alone, nearly double the number prescribed a decade ago, and a six per cent increase in the past year. According to recent research, one in three British women and one in 10 men now take the medication, including popular brands such as Prozac, Cipramil and Seroxat, at some point in their lives.

But a growing number of experts now believe depression is vastly overdiagnosed and the drugs can cause far more harm than good.

This week, a new organisation, the Council for Evidence-Based Psychiatry (CEP), whose members include psychiatrists, academics and withdrawal charities, is launching, to educate the public about the risks of antidepressants. A keynote speech will be given by Prof Peter Gøtzsche, co-founder of the Cochrane Collaboration, an international, non-profit organisation that examines vast amounts of medical data to help doctors and patients reach informed conclusions about health.

 

Read More Here

Enhanced by Zemanta

 

chinese baby with doctor Why Are Babies Dying in China After Receiving the Hepatitis B Vaccine?

 

Health Impact News

 

At least nine babies have died in China the past few weeks after being injected with the Hepatitis B vaccine.

 

In China, the Hepatitis B vaccine is given in three stages. The first shot is taken immediately after birth. The second and third shots of the vaccine are taken after a baby is one month and then six months old.

 

The pharmaceutical company manufacturing the vaccine has conducted quality control tests on the batch currently in the market, and has not found anything wrong with the vaccine. Similar statements have been made by health authorities:

 

The drug supervision department in Shenzhen says their test results indicate the vaccines were safe.

 

“According to our investigation, BioKangtai has produced the vaccine strictly under required standards. And their samples have passed our tests.” Wang Lifeng with Drug Administration of Shenzhen said.

 

The deaths, which have occurred within a very short time after receiving the vaccine, are gaining wide exposure in the China media. Because vaccines are almost always promoted as safe, injuries and deaths often are not associated with the vaccine, so there may be more deaths than have currently been reported. One of the deaths was reported by a family member after hearing about other babies dying shortly after receiving the vaccine in the media. When the family originally was fighting to save the baby from dying, they had not suspected the vaccine.

Read More Here

…..

NY Times

China Investigates Vaccine Maker After Deaths of Infants

 

 

SHANGHAI — Health authorities in China are investigating one of the nation’s biggest vaccine makers after eight infants died in the past two months following injections that were meant to immunize them against hepatitis B.

 

The government said this week that it had suspended the use of millions of doses of a hepatitis B vaccine produced by the manufacturer, Shenzhen Kangtai Biological Products. Government inspectors have been sent to examine the company’s facilities.

Six of the deaths have been linked to vaccines produced by Shenzhen Kangtai; the two other infant deaths occurred recently after the use of a hepatitis B vaccine produced by another drug maker, Beijing Tiantan Biological Products. The government did not say whether any action had been taken against Beijing Tiantan or its vaccines. Investigators have not determined the cause of the deaths or linked them directly to the injections, but the cases come at a time of growing public concern in China about food and drug safety problems.

In recent years, China has been troubled by a series of scandals, including tainted rice and milk and the mysterious appearance of thousands of dead pigs floating in the Huangpu River in Shanghai. China has vowed repeatedly to crack down on food and drug safety violations and has moved to strengthen the powers of health officials.

In the vaccine cases, the government is focusing on the role of Shenzhen Kangtai, a privately run drug maker formed in 1992 with government support and the cooperation of the American pharmaceutical company Merck.

Read More Here

…..

 

Enhanced by Zemanta

In this excerpt from the new book Crony Capitalism in America 2008-2012, Hunter Lewis exposes the incestuous relationship between government and the drug industry.

Lewis, who serves as president of ANH-USA’s board of directors, has written nine books on moral philosophy, psychology, and economics, including the widely acclaimed Are the Rich Necessary? (which the New York Times called “highly provocative and highly pleasurable”). He has contributed to the New York Times, the Times of London, the Washington Post, and the Atlantic Monthly, as well as numerous websites such as Forbes.com and RealClearMarkets.com.

In his new book, Lewis shows how private interests and politicians rely upon one another—political favors in exchange for money—a system known as crony capitalism. Where do private interests such as those on Wall Street or in the drug industry stop and Washington begins? It’s impossible to say anymore.

Chapter 15 is all about the FDA, and we thought our readers would enjoy this searing behind-the-scenes look at just how deeply the US Food and Drug Administration has enmeshed itself with the pharmaceutical industry:

Big Pharma and FDA:
A Marriage Not Made in Heaven

The drug industry at one time was called the patent medicine industry. This is still the more revealing name. Drug companies devote themselves to inventing non-natural molecules for use in medicine. Why non-natural? Because molecules previously occurring in nature cannot, as a rule, be patented. It is essential to develop a patentable medicine; only a medicine protected by a government patent can hope to recoup the enormous cost of taking a new drug through the government’s approval process.

Getting a new drug through the US Food and Drug Administration (FDA) is not just expensive ($1 billion on average). It also requires having the right people on your side. Drug companies know that they must hire former FDA employees to assist with the process. They also hire leading experts as consultants, some of the same experts who may be called on by the FDA to serve on its screening panels. Direct payments must also be made to support the FDA’s budget.

All these financial ties encourage a “wink and a nod” relationship between researchers working for drug companies and regulators, who are often the same people, thanks to the revolving door. As the Economist magazine writes:

Pharmaceutical companies bury clinical trials which show bad results for a drug and publish only those that show a benefit. The trials are often run on small numbers of unrepresentative patients, and the statistical analyses are massaged to give as rosy a picture as possible. Entire clinical trials are run not as trials at all, but as under-the-counter advertising campaigns designed to persuade doctors to prescribe a company’s drug.

The bad behavior extends far beyond the industry itself. Drug regulators, who do get access to some of the hidden results, often guard them jealously, even from academic researchers, seeming to serve the interests of the firms whose products they are supposed to police. The French journal Prescrire applied to Europe’s drug regulator for information on the diet drug rimonabant. The regulator sent back 68 pages in which virtually every sentence was blacked out. . . .

Medical journals frequently fail to perform basic checks on the papers they print, so all sorts of sharp practice goes uncorrected. Many published studies are not written by the academics whose names they bear, but by commercial ghostwriters paid by drug firms. Doctors are bombarded with advertising encouraging them to prescribe certain drugs. . . .

What the Economist calls “bad behavior” also spills over from the medical world to the financial world. Just since 2008, 75 people have been charged with trying to profit from inside information about drug approvals or company mergers related to patentable drugs. One of them, an FDA chemist named Cheng Yi Liang with access to the Agency’s approval database, pleaded guilty to insider trading on 25 companies for a total gain of $3.78 million over five years. Others with larger resources to invest have made much larger sums. Rod Rothstein, the US Attorney for Maryland who helped prosecute the FDA case, has noted that “healthcare is particularly attractive to criminals because so much turns on government regulatory approval.”

Dr. Ben Goldacre, author of Bad Pharma, summarizes the entire drug approval process as follows: “[It] is broken. . . . The people you should have been able to trust to fix [the] problems have failed you.”

Although the costs of drug approval keep growing, along with the related corruption, the financial payoff for those ultimately winning approval can be astronomical, because approval also brings with it a government-protected monopoly. Only FDA-approved drugs can be prescribed within government programs such as Medicare. Doctors may prescribe unapproved substances outside of Medicare, Medicaid, or the Veteran’s Administration, but by doing so risk losing their license to practice. Some approved drugs may be priced as high as $500,000 per year per patient.

The FDA will also discourage, and often ban, substances that might compete with approved drugs. When anti-depression drugs (based on extending the life of a hormone, serotonin, inside the body) were approved, the Agency promptly banned a natural substance, L-Tryptophan, that increased serotonin, even though the natural substance was much cheaper and had long been available. Many years later, after the anti-depression drugs were well established, Tryptophan was finally allowed back, but under restrictions that made it more expensive.

In general, the FDA maintains a resolutely hostile stance toward supplements. It will not allow any treatment claims to be made for them, no matter how much science there is to support it, unless they are brought through the FDA approval process and thus become drugs. The Agency understands that this is a classic “Catch-22.” Who can afford to spend up to a billion dollars to win FDA approval of a non-patented substance? The answer is obvious: no one. So the real FDA intent is simply to eliminate any competition for patented drugs, since these drugs pay the Agency’s bills.

This FDA policy prevents millions of Americans from hearing about food or supplement remedies that are safer and cheaper than drugs. It hurts the poor and the middle class. But, ironically, it also hurts the rich, even the crony capitalist rich. A national magazine ran a profile of a Wall Street billionaire sitting in his gigantic Connecticut mansion, popping acid blockers for a stomach problem that tormented him. He was totally unaware of research suggesting that most such ailments stemmed from too little acid, not too much, and that a few simple tablets containing hydrochloric acid, one of the cheapest supplements, would probably end his pain.

Why did the billionaire not know this? The answer could not be simpler: crony capitalist drug companies earn huge profits from acid blockers, and along with their friends in government at the FDA, succeed in keeping this information hidden. So there the billionaire sits in his great mansion, unable to enjoy it because of intense stomach pain.

Drug companies and the FDA are not alone in wishing to suppress supplement alternatives to hyper-expensive patented prescription drugs. They have allies among both politicians and doctors. For example, the Archives of Internal Medicine, run by the American Medical Association, and supported financially by drug companies, often publishes flimsy studies attacking supplements, and generally ignores the considerable scientific evidence in their favor.

One such study, published October 10, 2011, by University of Michigan researchers, purported to show that taking supplements could shorten your life. It caused a media feeding frenzy, with headlines everywhere. The problem was that this study, like its predecessors, was junk science. The women in the study were asked every six years what they had taken. They were supposed to remember what they had taken for the six-year period. The reports did not have to be specific: the word “multivitamin” could mean anything. Who knows what was taken or even it if was taken? It could also be synthetic or natural.

Those who reported taking “multivitamins” were found over time to be healthier on average than others and to live longer. But the authors of the study, who clearly had an anti-supplement agenda, made numerous “adjustments” attributing the good health to other factors. Once these arbitrary “adjustments” were made, they then concluded that supplements actually made these healthier than average and longer living people unhealthier. Even after the “adjustment,” the statistical evidence was weak to nonexistent, but that did not prevent media from all over the world reporting that supplements may hasten your death.

What was behind this? The AMA seems worried about competition for its brand of medicine, which focuses almost exclusively on conventional drugs and surgery. It is especially worried about competition from “integrative” doctors who include advice about food, supplements, and exercise in their practice. The AMA and its affiliates also have a tight relationship with drug companies, and depend on them for financial support in many forms, not just journal advertising. Both the AMA and drug companies thus seem determined to trash supplements and those giving advice on supplements.

Read More Here

*****************************************************

Dr John Rengen Virapen (1/4) Big Pharma Whistleblower Speaks Out at the AZK in Germany (Full Edit)

Philip Jonkers

Uploaded on Jul 9, 2009

Dr. John Rengen Virapen worked 35 years for Eli Lilly & Co as an executive. He now speaks out on the many crimes Big Pharma was and is responsible for and he himself also participated in. Unfortunately, many of its crimes go passed public awareness as it enjoys the unethical protection from its big allies, the mainstream media, the FDA and governments.

Check out accompanying blog carrying ample background material:
http://1phil4everyill.wordpress.com/2…

John Virapen’s website – with contact info and book order instructions:
http://www.johnvirapen.com/
http://www.side-effects-death.com/

New interview dated 2009-07-27 on blogtalkradio:
http://www.blogtalkradio.com/MedicalW…

Part 2


Part 3

Part 4

*****************************************************

Enhanced by Zemanta

  • Tens of thousands tested with experimental drugs not approved in the West
  • One study of a drug for heart conditions saw six out of 17 patients die
  • Sinister practice exposed in disturbing new Germany documentary

By Allan Hall In Berlin

Mail Online

Former Communist East Germany secretly sold its citizens to western pharmaceutical companies to use as human guinea pigs in drug trials.

Tens of thousands of sick people in the former German Democratic Republic were treated with medicines not approved in the West to see how effective they were.

Details of the top secret project have been unearthed in the files of the Stasi secret police in Berlin. The communist regime profited with millions in hard currency.

The bridge between East Germany and West Berlin pictured in the early 1960s. Recently opened files show how Stasi officials secretly sold citizens to western pharmaceutical companies to use as human guinea pigs The bridge between East Germany and West Berlin pictured in the early 1960s. Recently opened files show how Stasi officials secretly sold citizens to western pharmaceutical companies to use as human guinea pigs

But the human cost was high with dozens killed through side effects of drugs which had bypassed the normally stringent testing procedures demanded by western democracies.

Even worse, some patients received placebos – pills that did nothing at all – to gauge how they responded in comparison to others who were given proper medication.

The practice was exposed by journalists Stefan Hoge and Carsten Opitz and screened this week in Germany in a disturbing documentary entitled ‘Test and Dead’.

The Stasi files – miles and miles of yellowing paperwork which the hated secret police of East Germany failed to destroy when the country imploded in 1989 – revealed details of how it became one of the most important testing arenas for western drug companies.

The conspiracy involved the state, doctors and western big pharma firms.

 

Read Full Article Here

 

Health And Wellness Report

Cholesterol lowering statins found to damage peripheral nerves

Sayer Ji
GreenMedInfo
Statins

© GreenMedInfo

Have the nerve-damaging properties of statin drugs now been confirmed? There are over 300 adverse health effects associated with the use of this chemical class of cholesterol-lowering medications known as statins, with myotoxicity (muscle-damaging) and neurotoxicity (nerve-damaging) top on the list. When will the FDA step in and warn the public, as proof of the problem in the biomedical literature reaches an alarming level of clarity?

The neurotoxicity of statin drugs are back in the news. Following on the heels of the FDA decision earlier this year to require statin drugs manufacturers to add “memory loss” as a side effect of this chemical class, a new study in published in the Journal of Diabetes reveals a clear association between statin use and peripheral neuropathy in a US population 40 years of age and older.

The study found “The prevalence of peripheral neuropathy was significantly higher among those who used statins compared to those who did not (23.5% vs. 13.5%; p < 0.01),” which is a 75% increase in relative risk.

Case reports of statin-induced peripheral neuropathy have existed in the medical literature for over 15 years.[i] Now, larger human studies are confirming that statin drugs do damage to the peripheral nerves. Moreover, much of the damage is occurring below the threshold of clinical surveillance, silently causing harm in unsuspecting patients.

For example, in 2011, the results of a 36-month prospective clinical and neurophysiological follow-up of patients treated with statins over 3 years was published in the journal Neuro Endocrinology Letters, revealed in forty-two patients that despite the fact that they did not report subjective symptoms typical for peripheral neuropathy, damage was occurring.[ii] They concluded: “The study confirmed that long-term treatment with statins caused a clinically silent but still definite damage to peripheral nerves when the treatment lasts longer than 2 years.” Click the hyperlink to view all 9 studies on statin-induced peripheral neuropathy on Greenmedinfo.com. Or, view an even more sizeable dataset (54 studies) on statin-associated neurotoxicity.

While this research is adding to a growing awareness of the nerve-damaging properties of statins, this side effect is just the tip of a massive iceberg of under reported deleterious effects. For example, our project has identified 314 possible adverse effects of statins thus far. Conversely, we have identified a wide range of health benefits of cholesterol, running diametrically opposed to the over-simplification inherent in the cholesterol hypothesis (some say “cholesterol myth“) of heart disease causation.

For those who are interested in learning more about natural cholesterol modulating substances, or better, yet the wider array of research relevant to cardiovascular health, visit our Health Guide: Heart Health.

References:

Crossroads News : Changes In The World Around Us And Our Place In It

Corporate Assault on Our Lives And Our Health  :  Health – Pharmaceuticals – Rising Costs

Big Pharma’s profiteering has reached the breaking point: 45 percent of Americans can no longer afford prescriptions

 

by: Jonathan Benson, staff writer

 

(NaturalNews) Drug companies have gotten so greedy, and the American public so financially distressed, that nearly half of all Americans under the age of 65 who normally take prescription drugs are no longer doing so because they allegedly cannot afford it. This is according to a new report compiled by the Consumer Reports National Research Center (CRNRC), which also found that 63 percent of those in need of medical care are skipping trips to the doctor because of the high costs involved.

Based on a poll that included 1,158 adults over the age of 18, CRNRC found that 62 percent of Americans under the age of 65 avoided getting recommended medical tests in 2012 because of high costs, while just over half avoided getting a recommended medical procedure. In total, more than 80 percent of those polled indicated that they skipped either a medically-related procedure, medical test, doctor visit, or prescription because of the expense.

“When it comes to prescription drugs, consumers are spending on average $63 out of pocket every month, which can easily swallow up a big portion of the family budget,” said Lisa Gill, prescription drugs editor for Consumer Reports, in a recent press release about the findings. “It’s even worse for those without insurance for medicines, who pay upwards of $91 a month for their prescriptions.”

The number of adult patients under the age of 65 who skipped a doctor visit because they could not afford it jumped 16 percent last year, while the number who avoided a prescription jumped 19 percent. These same individuals cut various other things out of their lives as well, according to the report, including leisure activities, dining out, and entertainment.

According to the data, 28 percent of adults under the age of 65 with prescription drug benefits said they have cut back on entertainment and dining out because of financial difficulties. And 58 percent of those without benefits, or more than twice the number of those with benefits, indicated a reduction in these activities. Similar cut-backs were also observed among both groups for increased credit card use and a reduction in the amount of groceries purchased.

A similar survey conducted by the Henry J. Kaiser Family Foundation back in June found that roughly 60 percent of Americans avoided the doctor, eliminated or modified the doses of their prescriptions, avoided diagnostic tests, or otherwise altered their normal healthcare regimen to save money. The average cost of health care for a family of four with an employer-sponsored insurance plan also topped $20,000 for the first time ever this year.

Sources for this article include:

http://www.cbsnews.com

http://www.prweb.com/releases/2012/9/prweb9892917.htm

http://www.huffingtonpost.com